Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 13 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Integrated circuit packaging system with an integral-interposer-structure and method of manufacture thereof
Interactivity model for shared feedback on mobile devices
Method and apparatus for detecting an intermittent path to a storage system
Superconducting magnetizer
Solid state lighting devices with cellular arrays and associated methods of manufacturing
Optical analysis device, optical analysis method and computer program for optical analysis
Mobile tablet information handling system support
  Randomly Featured Patents
Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes and compositions containing
Method and apparatus for discovery of databases in a client server network
Stabilizing of structures
Protective switch
Mechanism for detecting position of a movable member
Lotion applicator
Shock tube initiator with phthalocyanine color indicator
Method and system for memory partitioning
Transcutaneous electrical nerve stimulator
Pultruded scalable shelving system